Treffer: Mathematical and Artificial Intelligence Techniques in Modern Drug Discovery: A Review.
Original Publication: New York : Alan R. Liss, c1981-
AbdelAziz, N. M., G. A. Fouad, S. Al‐Saeed, and A. M. Fawzy. 2025. “Deep Q‐Network (DQN) Model for Disease Prediction Using Electronic Health Records (EHRs).” Sci 7, no. 1: 14.
Agatonovic‐Kustrin, S., and R. Beresford. 2000. “Basic Concepts of Artificial Neural Network (ANN) Modeling and Its Application in Pharmaceutical Research.” Journal of Pharmaceutical and Biomedical Analysis 22, no. 5: 717–727.
Aghajanpour, S., H. Amiriara, M. Esfandyari‐Manesh, et al. 2025. “Utilizing Machine Learning for Predicting Drug Release From Polymeric Drug Delivery Systems.” Computers in Biology and Medicine 188: 109756.
Agrwal, A. 2023. “Computational Modelling and Simulations in Drug Design:” 35–52.
Agrwal, A., N. Chadha, and A. Sahu. 2025. “Molecular Docking and Virtual Screening to Investigate Lead Compounds for Veterinary Drug Development.” In Bioinformatics in Veterinary Science: Vetinformatics, edited by J. M. Kim and R. K. Pathak, 277–305. Springer. https://doi.org/10.1007/978-981-97-7395-4_12.
Agrwal, A., R. Saini, S. Bhandri, S. Verma, P. Srivastava, and O. Prakash. 2022. “Synthesis, ADMET, Drug Likeness and In Silico Activities of Benzimidazole Derivative.” Materials Today: Proceedings.
Agrwal, A., A. Verma, N. Chantola, S. Verma, and V. Kasana. 2022. “Synthesis, Molecular Docking and Extensive Structure Activity Relationship of Substituted DHP Derivatives: A New Class of Herbicides.” Journal of Environmental Science and Health. Part B: Pesticides, Food Contaminants, and Agricultural Wastes 57, no. 5: 379–420. https://doi.org/10.1080/03601234.2022.2062188.
Ahmadi Daryakenari, N., S. Wang, and G. Karniadakis. 2025. “CMINNs: Compartment Model Informed Neural Networks — Unlocking Drug Dynamics.” Computers in Biology and Medicine 184: 109392.
Allen, R., and H. Moore. 2019. “Perspectives on the Role of Mathematics in Drug Discovery and Development.” Bulletin of Mathematical Biology 81, no. 9: 3425–3435.
Altae‐Tran, H., B. Ramsundar, A. S. Pappu, and V. Pande. 2017. “Low Data Drug Discovery With One‐Shot Learning.” ACS Central Science 3, no. 4: 283–293.
Altman, D. G. 1990. “Practical Statistics for Medical Research.” In Practical Statistics for Medical Research. Chapman and Hall/CRC.
Alzubaidi, L., J. Zhang, A. J. Humaidi, et al. 2021. “Review of Deep Learning: Concepts, CNN Architectures, Challenges, Applications, Future Directions.” Journal of Big Data 8: 53.
Ancuceanu, R., P. C. Popovici, D. Drăgănescu, Ș. Busnatu, B. E. Lascu, and M. Dinu. 2024. “QSAR Regression Models for Predicting HMG‐CoA Reductase Inhibition.” Pharmaceuticals 17, no. 11: 1448.
Aruleba, R. T., T. A. Adekiya, N. Ayawei, et al. 2022. “COVID‐19 Diagnosis: A Review of Rapid Antigen, RT‐PCR and Artificial Intelligence Methods.” Bioengineering (Basel, Switzerland) 9, no. 4: 153.
Askr, H., E. Elgeldawi, H. Aboul Ella, Y. A. M. M. Elshaier, M. M. Gomaa, and A. E. Hassanien. 2023. “Deep Learning in Drug Discovery: An Integrative Review and Future Challenges.” Artificial Intelligence Review 56, no. 7: 5975–6037.
Atanasov, A. G., S. B. Zotchev, V. M. Dirsch, et al. 2021. “Natural Products in Drug Discovery: Advances and Opportunities.” Nature Reviews Drug Discovery 2021 20:3 20, no. 3: 200–216.
Austin, P. C., and S. van Buuren. 2023. “Logistic Regression vs. Predictive Mean Matching for Imputing Binary Covariates.” Statistical Methods in Medical Research 32, no. 11: 2172–2183.
Avanceña, A. L. V., and D. W. Hutton. 2020. “Optimization Models for HIV/AIDS Resource Allocation: A Systematic Review.” Value in Health 23, no. 11: 1509–1521.
Bajorath, J. 2013. “Chemoinformatics for Drug Discovery.” Chemoinformatics for Drug Discovery 1: 415.
Balaban, A. T. 1985. “Applications of Graph Theory in Chemistry.” Journal of Chemical Information and Computer Sciences 25, no. 3: 334–343.
Bals, J., and M. Epple. 2023. “Deep Learning for Automated Size and Shape Analysis of Nanoparticles in Scanning Electron Microscopy.” RSC Advances 13, no. 5: 2795–2802.
Barabási, A. L., and Z. N. Oltvai. 2004. “Network Biology: Understanding the Cell's Functional Organization.” Nature Reviews Genetics 5, no. 2: 101–113.
Basu, T., S. Engel‐Wolf, and O. Menzer. 2020. “The Ethics of Machine Learning in Medical Sciences: Where Do We Stand Today?” Indian Journal of Dermatology 65, no. 5: 358–364.
Beltagy, I., K. Lo, and A. Cohan. 2019. “SCIBERT: A Pretrained Language Model for Scientific Text.” In Proceedings of the 2019 Conference on Empirical Methods in Natural Language Processing and the 9th International Joint Conference on Natural Language Processing (EMNLP‐IJCNLP), 3615–3620. Association for Computational Linguistics.
Benkő, E., I. G. Ilič, K. Kristó, et al. 2022. “Predicting Drug Release Rate of Implantable Matrices and Better Understanding of the Underlying Mechanisms Through Experimental Design and Artificial Neural Network‐Based Modelling.” Pharmaceutics 14, no. 2: 228.
Berthold, M. R., N. Cebron, F. Dill, et al. 2008. “KNIME: The Konstanz Information Miner.” Studies in Classification, Data Analysis, and Knowledge Organization,: 319–326.
Bhandari, D. R., M. Baron, K. Shah, and S. Kandel. 2024. “Role of Statistics in Artificial Intelligence Technology.” NCC Journal 9, no. 1: 133–139.
Bhargava, H., A. Sharma, and P. Suravajhala. 2021. “Chemogenomic Approaches for Revealing Drug Target Interactions in Drug Discovery.” Current Genomics 22, no. 5: 328–338.
Blanco, J. L., A. B. Porto‐Pazos, A. Pazos, and C. Fernandez‐Lozano. 2018. “Prediction of High Anti‐Angiogenic Activity Peptides in Silico Using a Generalized Linear Model and Feature Selection.” Scientific Reports 8, no. 1: 15688.
Blasiak, A., J. Khong, and T. Kee. 2020. “CURATE.AI: Optimizing Personalized Medicine With Artificial Intelligence.” SLAS Technology 25, no. 2: 95–105.
Borgelt, C., T. Meinl, and M. Berthold. 2005. “MoSS: A Program for Molecular Substructure Mining.” In Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, 6–15.
Botchkarev, A. 2018. “Performance Metrics (Error Measures) in Machine Learning Regression, Forecasting and Prognostics: Properties and Typology”.
Brasil, J. 2024. Before Machine Learning Volume 2 ‐ Calculus for A.I: The Fundamental Mathematics for Data Science and Artificial Intelligence. Packt Publishing Limited.
Burch, K. J. 2019. “Chemical Applications of Graph Theory.” In Developments in Physical & Theoretical Chemistry, Mathematical Physics in Theoretical Chemistry, edited by S. M. Blinder and J. E. House, 261–294. Elsevier.
Butcher, E. C., E. L. Berg, and E. J. Kunkel. 2004. Systems Biology in Drug Discovery. Nature Biotechnology. October.
Buza, K., and L. Peška. 2017. “Drug–Target Interaction Prediction With Bipartite Local Models and Hubness‐Aware Regression.” Neurocomputing 260: 284–293.
Buza, K., L. Peška, and J. Koller. 2020. “Modified Linear Regression Predicts Drug‐Target Interactions Accurately.” PLoS One 15, no. 4: e0230726.
Carlson, R. 2001. “Design of Experiments, Principles and Applications, L. Eriksson, E. Johansson, N. Kettaneh‐ Wold, C. Wikström and S. Wold, Umetrics AB, Umeå Learnways AB, Stockholm, 2000, ISBN 91‐973730‐0‐1, Xii + 329 Pp.” Journal of Chemometrics 15, no. 5: 495–496.
Cassidy, J. W., and J. W. Cassidy. 2020. “Applications of Machine Learning in Drug Discovery I: Target Discovery and Small Molecule Drug Design.” In Artificial Intelligence in Oncology Drug Discovery and Development. IntechOpen.
Catacutan, D. B., J. Alexander, A. Arnold, and J. M. Stokes. 2024. “Machine Learning in Preclinical Drug Discovery.” Nature Chemical Biology 2024 20:8 20, no. 8: 960–973.
Chen, H., O. Engkvist, Y. Wang, M. Olivecrona, and T. Blaschke. 2018. “The Rise of Deep Learning in Drug Discovery.” Drug Discovery Today 23, no. 6: 1241–1250.
Cifuentes‐Faura, J., U. Faura‐Martínez, and M. Lafuente‐Lechuga. 2022. “Mathematical Modeling and the Use of Network Models as Epidemiological Tools.” Mathematics 10, no. 18: 3347.
Clancey, W. J., and E. H. Shortliffe. 1984. Readings in Medical Artificial Intelligence: The First Decade. Addison‐Wesley.
Collett, D. 2015. “Modelling Survival Data in Medical Research.”.
Corecco, S., G. Adorni, and L. M. Gambardella. 2023. “Proximal Policy Optimization‐Based Reinforcement Learning and Hybrid Approaches to Explore the Cross Array Task Optimal Solution.” Machine Learning and Knowledge Extraction 5, no. 4: 1660–1679.
Cotton, F. A. 1971. Chemical Applications of Group Theory (3rd ed., 480. Wiley).
Cvetkovic, D. M., M. Doob, H. Sachs, J. Ambrosius, B. Verlag, and H. Leipzig. 2012. Spectra of Graphs Theory and Applications.
Daryaee, F., and P. J. Tonge. 2019. “Pharmacokinetic‐Pharmacodynamic Models That Incorporate Drug‐Target Binding Kinetics.” Current Opinion in Chemical Biology 50: 120–127.
Das, P. J., C. Preuss, and B. Mazumder. 2016. “Artificial Neural Network as Helping Tool for Drug Formulation and Drug Administration Strategies.” In Artificial Neural Network for Drug Design, Delivery and Disposition, 263–276.
David, C. C., and D. J. Jacobs. 2014. “Principal Component Analysis: A Method for Determining the Essential Dynamics of Proteins.” Methods in Molecular Biology (Clifton, N.J.) 1084: 193.
Deb, K., A. Pratap, S. Agarwal, and T. Meyarivan. 2002. “A Fast and Elitist Multiobjective Genetic Algorithm: NSGA‐II.” IEEE Transactions on Evolutionary Computation 6, no. 2: 182–197.
Dickenstein, A. 2020. “Algebraic Geometry Tools in Systems Biology.” Notices of the American Mathematical Society 67, no. 11: 1.
Dimasi, J. A., L. Feldman, A. Seckler, and A. Wilson. 2010. “Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs.” Clinical Pharmacology & Therapeutics 87, no. 3: 272–277.
Dixon, S. L., J. Duan, E. Smith, C. D. Von Bargen, W. Sherman, and M. P. Repasky. 2016. “AutoQSAR: An Automated Machine Learning Tool for Best‐Practice Quantitative Structure‐Activity Relationship Modeling.” Future Medicinal Chemistry 8, no. 15: 1825–1839.
Dong, J., D. S. Cao, H. Y. Miao, et al. 2015. “ChemDes: An Integrated Web‐Based Platform for Molecular Descriptor and Fingerprint Computation.” Journal of Cheminformatics 7, no. 1: 60.
Dorigo, M., T. Stützle, and B. Hölldobler. 2004. Ant Colony Optimization.
Droschinsky, A., L. Humbeck, O. Koch, N. M. Kriege, P. Mutzel, and T. Schäfer. 2022. “Graph‐Based Methods for Rational Drug Design.” Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 13201: 76–96.
Farid, M., M. Palmblad, H. Hallman, and J. Vänngård. 2023. “A Binary Decision Tree Approach for Pharmaceutical Project Portfolio Management.” Decision Analytics Journal 7: 100228.
Felmlee, M. A., M. E. Morris, and D. E. Mager. 2012. “Mechanism‐Based Pharmacodynamic Modeling.” In Methods in Molecular Biology (Clifton, N.J.) (929, 583.
Fonner, D. E., J. R. Buck, and G. S. Banker. 1970. “Mathematical Optimization Techniques in Drug Product Design and Process Analysis.” Journal of Pharmaceutical Sciences 59, no. 11: 1587–1596.
Fujisawa, K., M. Shimo, Y. H. Taguchi, S. Ikematsu, and R. Miyata. 2021. “PCA‐Based Unsupervised Feature Extraction for Gene Expression Analysis of COVID‐19 Patients.” Scientific Reports 11, no. 1: 17351.
GabAllah, N., and A. Rafea. 2022. “Drug Protein Interaction Extraction Using SciBERT Based Deep Learning Model:” 157–165.
Gabrielsson, J., and D. Weiner. 2016. Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications. Apotekarsocieteten.
Gad, A. G. 2022. “Particle Swarm Optimization Algorithm and Its Applications: A Systematic Review.” Archives of Computational Methods in Engineering 29, no. 5: 2531–2561.
Gasteiger, J., and T. Engel. 2004. “Chemoinformatics: A Textbook.” In Chemoinformatics: A Textbook. Taylor and Francis.
George, E. P., and J. S. H. W. G. H. Box. 2005. Statistics for Experiments. Design, Innovation, and Discovery (2nd ed. John Willey & Sons).
Gordon, D. E., G. M. Jang, M. Bouhaddou, et al. 2020. “A SARS‐CoV‐2‐Human Protein‐Protein Interaction Map Reveals Drug Targets and Potential Drug‐Repurposing.” bioRxiv: The Preprint Server for Biology.
Gramatica, R., T. Di Matteo, S. Giorgetti, M. Barbiani, D. Bevec, and T. Aste. 2014. “Graph Theory Enables Drug Repurposing – How a Mathematical Model Can Drive the Discovery of Hidden Mechanisms of Action.” PLoS One 9, no. 1: e84912.
Gupta, A., A. T. Müller, B. J. H. Huisman, J. A. Fuchs, P. Schneider, and G. Schneider. 2018. “Generative Recurrent Networks for De Novo Drug Design.” Molecular Informatics 37, no. 1: 1700111.
Gupta, R., D. Srivastava, M. Sahu, S. Tiwari, R. K. Ambasta, and P. Kumar. 2021. “Artificial Intelligence to Deep Learning: Machine Intelligence Approach for Drug Discovery.” Molecular Diversity 25, no. 3: 1315–1360.
Gutman, I., and Ž. Tomović. 2000. “Relation Between Distance‐Based Topological Indices.” Journal of Chemical Information and Computer Sciences 40, no. 6: 1333–1336.
Hall, M., E. Frank, G. Holmes, B. Pfahringer, P. Reutemann, and I. H. Witten. 2009. “The WEKA Data Mining Software.” ACM SIGKDD Explorations Newsletter 11, no. 1: 10–18.
He, Y., and M. Kayaalp. 2008. “Biological Entity Recognition With Conditional Random Fields.” AMIA. Annual Symposium Proceedings. AMIA Symposium 2008: 293–297.
Heid, E., K. P. Greenman, Y. Chung, et al. 2024. “Chemprop: A Machine Learning Package for Chemical Property Prediction.” Journal of Chemical Information and Modeling 64, no. 1: 9–17.
Hong, Z., J. G. Pauloski, L. Ward, K. Chard, B. Blaiszik, and I. Foster. 2021. “Models and Processes to Extract Drug‐Like Molecules From Natural Language Text.” Frontiers in Molecular Biosciences 8: 636077.
Huang, X. H., and Q. S. Zheng. 2010. Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications. American Journal of Pharmaceutical Education. April.
Ibeas, A., and M. De La Sen. 2006. “Artificial Intelligence and Graph Theory Tools for Describing Switched Linear Control Systems.” Applied Artificial Intelligence 20, no. 9: 703–741.
Iroju, O. G., and J. O. Olaleke. 2015. “A Systematic Review of Natural Language Processing in Healthcare.” International Journal of Information Technology and Computer Science 7, no. 8: 44–50.
James, G., D. Witten, T. Hastie, R. Tibshirani, and J. Taylor. 2023. “Unsupervised Learning:” 503–556.
Janairo, J. I. B. 2023a. “Support Vector Machine in Drug Design.” In Cheminformatics, QSAR and Machine Learning Applications for Novel Drug Development, 161–179.
Janairo, J. I. B. 2023b. “A Machine Learning Classification Model for Cholesterol‐Lowering Peptides.” Artificial Intelligence Chemistry 1, no. 2: 100026.
Jarantow, S. W., E. D. Pisors, and M. L. Chiu. 2023. “Introduction to the Use of Linear and Nonlinear Regression Analysis in Quantitative Biological Assays.” Current Protocols 3, no. 6: e801.
Jean‐Loup Faulon, A. B. 2010. Handbook of Chemoinformatics Algorithms (1st ed. Louis J. Gross).
Jiang, J., L. Chen, L. Ke, et al. 2025. “A Review of Transformer Models in Drug Discovery and Beyond.” Journal of Pharmaceutical Analysis 15, no. 6: 101081.
Kar Nandan Girija. 2020. “(PDF) Probability and It's Use in Artificial Intelligence.” (December).
Kauffman, S. A. 1992. “The Origins of Order: Self‐Organization and Selection in Evolution:” 61–100.
Khamis, M. A., W. Gomaa, and W. F. Ahmed. 2015. “Machine Learning in Computational Docking.” Artificial Intelligence in Medicine 63, no. 3: 135–152.
Kirkpatrick, S., C. D. Gelatt, and M. P. Vecchi. 1983. “Optimization by Simulated Annealing.” Science 220, no. 4598: 671–680.
Kitchen, D. B., H. Decornez, J. R. Furr, and J. Bajorath. 2004. “Docking and Scoring in Virtual Screening for Drug Discovery: Methods and Applications.” Nature Reviews Drug Discovery 3, no. 11: 935–949.
Knisley, D., and J. Knisley. 2007. “Graph Theoretic Models in Chemistry and Molecular Biology.” In Handbook of Applied Algorithms: Solving Scientific, Engineering and Practical Problems, 85–113.
KP Jayatunga, M., M. Ayers, L. Bruens, D. Jayanth, and C. Meier. 2024. “How Successful Are AI‐Discovered Drugs in Clinical Trials? A First Analysis and Emerging Lessons.” Drug Discovery Today 29, no. 6: 104009.
Kumar, Y., K. Kaur, and G. Singh. 2020. “Machine Learning Aspects and Its Applications Towards Different Research Areas.” In Proceedings of International Conference on Computation, Automation and Knowledge Management, ICCAKM 2020, 150–156.
Lamberti, M. J., M. Wilkinson, B. A. Donzanti, et al. 2019. “A Study on the Application and Use of Artificial Intelligence to Support Drug Development.” Clinical Therapeutics 41, no. 8: 1414–1426.
Lambrinidis, G., and A. Tsantili‐Kakoulidou. 2021. “Multi‐Objective Optimization Methods in Novel Drug Design.” Expert Opinion on Drug Discovery 16, no. 6: 647–658.
Land, A. H., and A. G. Doig. 1960. “An Automatic Method of Solving Discrete Programming Problems.” Econometrica 28, no. 3: 497.
Laubenbacher, R., F. Hinkelmann, D. Murrugarra, and A. Veliz‐Cuba. 2014. “Algebraic Models and Their Use in Systems Biology.” Natural Computing Series 48: 443–474.
Le, N. Q. K. 2023. “Predicting Emerging Drug Interactions Using GNNs.” Nature Computational Science 3, no. 12: 1007–1008.
Leach, A. R., and V. J. Gillet. 2007. An Introduction to Chemoinformatics. An Introduction To Chemoinformatics. Springer Netherlands.
Leardi, R. 2001. “Genetic Algorithms in Chemometrics and Chemistry: A Review.” Journal of Chemometrics 15, no. 7: 559–569.
Lee, D. K., J. In, and S. Lee. 2015. “Standard Deviation and Standard Error of the Mean.” Korean Journal of Anesthesiology 68, no. 3: 220–223.
Lee, J., W. Yoon, S. Kim, et al. 2020. “BioBERT: A Pre‐Trained Biomedical Language Representation Model for Biomedical Text Mining.” Bioinformatics 36, no. 4: 1234–1240.
Leelananda, S. P., and S. Lindert. 2016. “Computational Methods in Drug Discovery.” Beilstein Journal of Organic Chemistry 12, no. 1: 2694–2718.
Li, J., A. Fu, and L. Zhang. 2019. “An Overview of Scoring Functions Used for Protein–Ligand Interactions in Molecular Docking.” Interdisciplinary Sciences: Computational Life Sciences 11, no. 2: 320–328.
Li, P., Y. Fu, and Y. Wang. 2015. “Network Based Approach to Drug Discovery: A Mini Review.” Mini‐Reviews in Medicinal Chemistry 15, no. 8: 687–695.
Li, Y. 2018. “Deep Reinforcement Learning: An Overview”.
Lin, C. C., Y. C. Wang, J. Y. Chen, et al. 2008. “Artificial Neural Network Prediction of Clozapine Response With Combined Pharmacogenetic and Clinical Data.” Computer Methods and Programs in Biomedicine 91, no. 2: 91–99.
Lipinski, C. A., F. Lombardo, B. W. Dominy, and P. J. Feeney. 2001. “Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings.” Advanced Drug Delivery Reviews 46, no. 1–3: 3–26.
Liu, W., Z. Wang, X. Liu, N. Zeng, Y. Liu, and F. E. Alsaadi. 2017. “A Survey of Deep Neural Network Architectures and Their Applications.” Neurocomputing 234: 11–26.
Liu, Y., S. Tang, C. Fernandez‐Lozano, et al. 2017. “Experimental Study and Random Forest Prediction Model of Microbiome Cell Surface Hydrophobicity.” Expert Systems With Applications 72: 306–316.
Lo, Y. C., S. E. Rensi, W. Torng, and R. B. Altman. 2018. “Machine Learning in Chemoinformatics and Drug Discovery.” Drug Discovery Today 23, no. 8: 1538–1546.
Lovrić, M., J. M. Molero, and R. Kern. 2019. “PySpark and RDKit: Moving Towards Big Data in Cheminformatics.” Molecular Informatics 38, no. 6: 1800082.
Maiolo, D. 2024. “The Role of Differential Equations in Enhancing AI Predictive Models ‐ David Maiolo.”.
Mak, K. K., and M. R. Pichika. 2019. “Artificial Intelligence in Drug Development: Present Status and Future Prospects.” Drug Discovery Today 24, no. 3: 773–780.
Makhija, M. T., and V. M. Kulkarni. 2001. “Eigen Value Analysis of HIV‐1 Integrase Inhibitors.” Journal of Chemical Information and Computer Sciences 41, no. 6: 1569–1577.
Meng, X., J. Bradley, B. Yavuz, et al. 2016. “MLlib: Machine Learning in Apache Spark.” Journal of Machine Learning Research 17, no. 34: 1–7.
Meng, X.‐Y., H.‐X. Zhang, M. Mezei, and M. Cui. 2011. “Molecular Docking: A Powerful Approach for Structure‐Based Drug Discovery.” Current Computer Aided‐Drug Design 7, no. 2: 146–157.
Mezey, P. G. 1985. “Group Theory of Electrostatic Potentials: A Tool for Quantum Chemical Drug Design.” International Journal of Quantum Chemistry 28, no. 12 S: 113–122.
Mishra, P., U. Singh, C. M. Pandey, P. Mishra, and G. Pandey. 2019. “Application of Student's t‐Test, Analysis of Variance, and Covariance.” Annals of Cardiac Anaesthesia 22, no. 4: 407–411.
Mohammad Elbarjo, R., O. A. AL‐Sammarraie, and H. khaleelalfarrah. 2025. “The Role of Linear Algebra in Artificial Intelligence: Foundations, Applications, and Innovations.” International Journal of Engineering Inventions 14, no. 3: 21–23.
Molecular Operating Environment (MOE). 2014. “Molecular Operating Environment (MOE) | MOEsaic | PSILO”.
Montgomery, D. C. 2020. Design and Analysis of Experiments (10th ed. Wiley).
Moore, H. 2018. “How to Mathematically Optimize Drug Regimens Using Optimal Control.” Journal of Pharmacokinetics and Pharmacodynamics 45, no. 1: 127–137.
Nikolova, N., and J. Jaworska. 2004. “Approaches to Measure Chemical Similarity ‐ A Review.” QSAR and Combinatorial Science 22, no. 9–10: 1006–1026.
de Oliveira, A. M. 2022. “Quantitative Structure‐Activity Relationships (QSARs).” In Computer Aided Drug Design (CADD): From Ligand‐Based Methods to Structure‐Based Approaches, 101–123.
Özcan, S., S. Levent, and N. Ö. Can. 2023. “Quality by Design Approach With Design of Experiment for Sample Preparation Techniques.” Advances in Sample Preparation 7: 100079.
Paszke, A., S. Gross, F. Massa, et al. 2019. “PyTorch: An Imperative Style, High‐Performance Deep Learning Library.” In Proceedings of the 33rd International Conference on Neural Information Processing Systems, 8026–8037. Curran Associates Inc.
Pedregosa FABIANPEDREGOSA, F., V. Michel, O. Grisel OLIVIERGRISEL, et al. 2011. “Scikit‐Learn: Machine Learning in Python Gaël Varoquaux Bertrand Thirion Vincent Dubourg Alexandre Passos PEDREGOSA, VAROQUAUX, GRAMFORT ET AL. Matthieu Perrot.” Journal of Machine Learning Research 12: 2825–2830.
Peter, S. C., J. K. Dhanjal, V. Malik, et al. 2018. “Quantitative Structure‐Activity Relationship (QSAR): Modeling Approaches to Biological Applications.” Encyclopedia of Bioinformatics and Computational Biology: ABC of Bioinformatics 1–3: 661–676.
Pilot, W. P. 2023. “Pipeline Pilot Overview:” 1–6.
Piroozmand, F., F. Mohammadipanah, and H. Sajedi. 2023. “Artificial Neural Network (ANN) in Drug Delivery.” In A Handbook of Artificial Intelligence in Drug Delivery, 97–122.
Podina, L., A. Ghodsi, and M. Kohandel. 2025. “Learning Chemotherapy Drug Action via Universal Physics‐Informed Neural Networks.” Pharmaceutical Research 42, no. 4: 593–612.
Poleksic, A. 2023. “Hyperbolic Matrix Factorization Improves Prediction of Drug‐Target Associations.” Scientific Reports 13, no. 1: 959.
Popova, M., O. Isayev, and A. Tropsha. 2018. “Deep Reinforcement Learning for de Novo Drug Design.” Science Advances 4, no. 7: eaap7885.
Popova, M., M. Shvets, J. Oliva, and O. Isayev. 2019. “MolecularRNN: Generating Realistic Molecular Graphs With Optimized Properties”.
Raissi, M., P. Perdikaris, N. Ahmadi, and G. E. Karniadakis. 2024. “Physics‐Informed Neural Networks and Extensions”.
Randić, M. 1985. “Graph Theoretical Approach to Structure‐Activity Studies: Search for Optimal Antitumor Compounds.” Progress in Clinical and Biological Research 172A: 309–318.
Raymond, J. W., and P. Willett. 2002. “Maximum Common Subgraph Isomorphism Algorithms for the Matching of Chemical Structures.” Journal of Computer‐Aided Molecular Design 16, no. 7: 521–533.
Riera‐Fernandez, P., C. R. Munteanu, J. Dorado, R. Martin‐Romalde, A. Duardo‐Sanchez, and H. Gonzalez‐Diaz. 2011. “From Chemical Graphs in Computer‐Aided Drug Design to General Markov‐Galvez Indices of Drug‐Target, Proteome, Drug‐Parasitic Disease, Technological, and Social‐Legal Networks.” Current Computer Aided‐Drug Design 7, no. 4: 315–337.
Riva, L., S. Yuan, X. Yin, et al. 2020. “A Large‐Scale Drug Repositioning Survey for SARS‐CoV‐2 Antivirals.” bioRxiv: The Preprint Server for Biology.
Roderick, M., J. MacGlashan, and S. Tellex. 2017. “Implementing the Deep Q‐Network”.
Rodrigues, T., and G. J. L. Bernardes. 2020. “Machine Learning for Target Discovery in Drug Development.” Current Opinion in Chemical Biology 56: 16–22.
Rodriguez, M. Z., C. H. Comin, D. Casanova, et al. 2019. “Clustering Algorithms: A Comparative Approach.” PLoS One 14, no. 1: e0210236.
Roucairol, M., A. Georgiou, T. Cazenave, F. Prischi, and O. E. Pardo. 2024. “DrugSynthMC: An Atom‐Based Generation of Drug‐Like Molecules With Monte Carlo Search.” Journal of Chemical Information and Modeling 64, no. 18: 7097–7107.
Rudrapal, M., S. J. Khairnar, A. G. Jadhav, M. Rudrapal, S. J. Khairnar, and A. G. Jadhav. 2020. “Drug Repurposing (DR): An Emerging Approach in Drug Discovery.” In Drug Repurposing ‐ Hypothesis, Molecular Aspects and Therapeutic Applications.
Rühle, B., J. F. Krumrey, and V. D. Hodoroaba. 2021. “Workflow Towards Automated Segmentation of Agglomerated, Non‐Spherical Particles From Electron Microscopy Images Using Artificial Neural Networks.” Scientific Reports 11, no. 1: 4942.
Sarker, I. H. 2021. “Machine Learning: Algorithms, Real‐World Applications and Research Directions.” SN Computer Science 2, no. 3: 160.
Scarselli, F., M. Gori, T. Ah Chung Tsoi, M. Hagenbuchner, and G. Monfardini. 2009. “The Graph Neural Network Model.” IEEE Transactions on Neural Networks 20, no. 1: 61–80.
Schmitt, W., and S. Willmann. 2004. “Physiology‐Based Pharmacokinetic Modeling: Ready to Be Used.” Drug Discovery Today: Technologies 1, no. 4: 449–456.
Schulman, J., F. Wolski, P. Dhariwal, A. Radford, and O. Klimov. 2017. “Proximal Policy Optimization Algorithms.”.
Schwaller, P., T. Laino, T. Gaudin, et al. 2019. “Molecular Transformer: A Model for Uncertainty‐Calibrated Chemical Reaction Prediction.” ACS Central Science 5, no. 9: 1572–1583.
Shahriari, B., K. Swersky, Z. Wang, R. P. Adams, and N. de Freitas. 2016. “Taking the Human out of the Loop: A Review of Bayesian Optimization.” Proceedings of the IEEE 104, no. 1: 148–175.
Shirali, A., V. Stebliankin, U. Karki, J. Shi, P. Chapagain, and G. Narasimhan. 2025. “A Comprehensive Survey of Scoring Functions for Protein Docking Models.” BMC Bioinformatics 26, no. 1: 25.
Shyr, Z. A., K. Gorshkov, C. Z. Chen, and W. Zheng. 2020. “Drug Discovery Strategies for SARS‐CoV‐2.” The Journal of Pharmacology and Experimental Therapeutics 375, no. 1: 127–138.
Siau, K. 2018. “A Qualitative Research on Marketing and Sales in the Artificial Intelligence Age Supply Chain Management View Project.” Information Systems Conference. (September): 18, 2018.
Singh, A. 2012. “DeepChem and Its Importance in Drug Discovery and Biology.” IJEDR2104012 International Journal of Engineering Development and Research 9: 56.
Singh, K. 2023. “The Role of Mathematics in Artificial Intelligence and Machine Learning.” International Journal for Research Publication and Seminar 14, no. 5: 186–197.
Singh, R., and K. Mukhopadhyay. 2011. “Survival Analysis in Clinical Trials: Basics and Must Know Areas.” Perspectives in Clinical Research 2, no. 4: 145.
Smith, R. G., and A. Farquhar. 2000. “The Road Ahead for Knowledge Management: An AI Perspective.” AI Magazine 21, no. 4: 17.
Strang, G. 1988. Linear Algebra and Its Applications Third Edition. Linear Algebra and its Applications.
Taguchi, Y., M. Iwadate, and H. Umeyama. 2015. “Principal Component Analysis‐Based Unsupervised Feature Extraction Applied to in Silico Drug Discovery for Posttraumatic Stress Disorder‐Mediated Heart Disease.” BMC Bioinformatics 16, no. 1: 139.
Taguchi, Y. H. 2016. “Principal Component Analysis Based Unsupervised Feature Extraction Applied to Publicly Available Gene Expression Profiles Provides New Insights into the Mechanisms of Action of Histone Deacetylase Inhibitors.” Neuroepigenetics 8: 1–18.
Talebi, S., E. Tong, A. Li, G. Yamin, G. Zaharchuk, and M. R. K. Mofrad. 2024. “Exploring the Performance and Explainability of Fine‐Tuned BERT Models for Neuroradiology Protocol Assignment.” BMC Medical Informatics and Decision Making 24, no. 1: 40.
Talevi, A., J. F. Morales, G. Hather, et al. 2020. “Machine Learning in Drug Discovery and Development Part 1: A Primer.” CPT: Pharmacometrics & Systems Pharmacology 9, no. 3: 129–142.
Tan, D., C. J. Henry, and C. K. Leung. 2025. “A Guided Variational Autoencoder for Targeted Molecule Optimization in Drug Discovery.” Journal of Healthcare Informatics Research,: 1–21.
Tanabe, L., and W. J. Wilbur. 2002. “Tagging Gene and Protein Names in Biomedical Text.” Bioinformatics 18, no. 8: 1124–1132.
Trajanov, D., V. Trajkovski, M. Dimitrieva, et al. 2023. “Review of Natural Language Processing in Pharmacology.” Pharmacological Reviews 75, no. 4: 714–738.
Tripathi, N., M. K. Goshisht, S. K. Sahu, and C. Arora. 2021. “Applications of Artificial Intelligence to Drug Design and Discovery in the Big Data Era: A Comprehensive Review.” Molecular Diversity 25, no. 3: 1643–1664.
Tropsha, A. 2010. “Best Practices for QSAR Model Development, Validation, and Exploitation.” Molecular Informatics 29, no. 6–7: 476–488.
Tsuji, S., T. Hase, A. Yachie‐Kinoshita, et al. 2021. “Artificial Intelligence‐Based Computational Framework for Drug‐Target Prioritization and Inference of Novel Repositionable Drugs for Alzheimer's Disease.” Alzheimer's Research & Therapy 13, no. 1: 92.
Turchin, A., S. Masharsky, and M. Zitnik. 2023. “Comparison of BERT Implementations for Natural Language Processing of Narrative Medical Documents.” Informatics in Medicine Unlocked 36: 101139.
Upton, R., and D. Mould. 2014. “Basic Concepts in Population Modeling, Simulation, and Model‐Based Drug Development: Part 3—Introduction to Pharmacodynamic Modeling Methods”.
Vamathevan, J., D. Clark, P. Czodrowski, et al. 2019. “Applications of Machine Learning in Drug Discovery and Development.” Nature Reviews Drug Discovery 18, no. 6: 463–477.
Vlachakis, D., and P. Vlamos. 2021. “Mathematical Multidimensional Modelling and Structural Artificial Intelligence Pipelines Provide Insights for the Designing of Highly Specific AntiSARS‐CoV2 Agents.” Mathematics in Computer Science 15, no. 4: 877–888.
Wang, Y., and J. Zeng. 2013. “Predicting Drug‐Target Interactions Using Restricted Boltzmann Machines.” Bioinformatics 29, no. 13: i126–i134.
Wang, Z., J. D. Butner, V. Cristini, and T. S. Deisboeck. 2015. “Integrated PK‐PD and Agent‐Based Modeling in Oncology.” Journal of Pharmacokinetics and Pharmacodynamics 42, no. 2: 179–189.
Wang, Z., and T. S. Deisboeck. 2014. “Mathematical Modeling in Cancer Drug Discovery.” Drug Discovery Today 19, no. 2: 145–150.
Weininger, D. 1988. “SMILES, a Chemical Language and Information System: 1: Introduction to Methodology and Encoding Rules.” Journal of Chemical Information and Computer Sciences 28, no. 1: 31–36.
Wirtz, B. W., J. C. Weyerer, and C. Geyer. 2019. “Artificial Intelligence and the Public Sector—Applications and Challenges.” International Journal of Public Administration 42, no. 7: 596–615.
Withers, C. A., A. M. Rufai, A. Venkatesan, et al. 2025. “Natural Language Processing in Drug Discovery: Bridging the Gap Between Text and Therapeutics With Artificial Intelligence.” Expert Opinion on Drug Discovery 20, no. 6: 765–783.
Wold, S., K. Esbensen, and P. Geladi. 1987. “Principal Component Analysis.” Chemometrics and Intelligent Laboratory Systems 2, no. 1–3: 37–52.
Yadava, U. 2018. “Search Algorithms and Scoring Methods in Protein‐Ligand Docking.” Endocrinology & Metabolism International Journal 6, no. 6: 359–367.
Yamanishi, Y., M. Araki, A. Gutteridge, W. Honda, and M. Kanehisa. 2008. “Prediction of Drug–Target Interaction Networks From the Integration of Chemical and Genomic Spaces.” Bioinformatics 24, no. 13: i232–i240.
Yap, C. W. 2011. “PaDEL‐Descriptor: An Open Source Software to Calculate Molecular Descriptors and Fingerprints.” Journal of Computational Chemistry 32, no. 7: 1466–1474.
Zhang, Y., Q. Yao, L. Yue, et al. 2023. “Emerging Drug Interaction Prediction Enabled by a Flow‐Based Graph Neural Network With Biomedical Network.” Nature Computational Science 3, no. 12: 1023–1033.
Zhavoronkov, A., Y. A. Ivanenkov, A. Aliper, et al. 2019. “Deep Learning Enables Rapid Identification of Potent DDR1 Kinase Inhibitors.” Nature Biotechnology 37, no. 9: 1038–1040.
Zheng, Y., and R. Zhang. 2022. “A Novel Drug‐Target Interaction Predication Model via Singular Value Decomposition and Collaborative Filtering.” Proceedings ‐ 2022 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2022: 1417–1422.
Zhou, J., G. Cui, S. Hu, et al. 2020. “Graph Neural Networks: A Review of Methods and Applications.” AI Open 1: 57–81.
Zhu, Y., L. Li, H. Lu, A. Zhou, and X. Qin. 2020. “Extracting Drug‐Drug Interactions From Texts With BioBERT and Multiple Entity‐Aware Attentions.” Journal of Biomedical Informatics 106: 103451.
Zugmaier, G. 2025. “Boolean Algebra (Mathematical Logic) for Computational Differential Diagnosis in Medicine.” Journal of Clinical Research and Reports 18, no. 01: 01–04.
Živanović, M. N., and N. Filipović. 2024. “System Biology Modeling for Drug Optimization.” In In Silico Clinical Trials for Cardiovascular Disease: A Finite Element and Machine Learning Approach, 105–138. Springer Nature.
Weitere Informationen
The future of drug research is intrinsically connected to the continuous advancement and prudent integration of Artificial intelligence (AI) and mathematics. By addressing challenges and leveraging possibilities, the pharmaceutical industry may fully harness the potential of AI to develop innovative and effective treatments for diverse diseases. In our opinion, finding new drugs takes long time and funds, and in the past, it was mostly done manually. AI has changed this sector completely, making drug manufacturing faster, cheaper, and more specific. This review presents the pertinent literature on drug discovery utilizing mathematical modeling and AI tools and methodologies implemented at every stage of drug development to expedite the research process and mitigate risk and costs in clinical trials, it also presents that how mathematical modeling and AI algorithms can be used together at several stages of drug development. There is a lot of focus on how mathematical frameworks like Linear Algebra, optimization, statistical modeling, graph theory and differential equations may operate along with the techniques of AI like machine learning (ML), deep learning (DL), reinforcement learning (RL), natural language processing (NLP) and transfer learning (TL) and the problems that are now being faced, the tools and datasets that are accessible, and what the future holds for this field, which is changing quickly.
(© 2025 Wiley Periodicals LLC.)